Samsara BioCapital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,065,413
| Closed | -$21.3M | – | 57 |
|
|
2022
Q3 | $21.3M | Sell |
1,065,413
-500,113
| -32% | -$9.98M | 4.96% | 5 |
|
|
2022
Q2 | $10.8M | Hold |
1,565,526
| – | – | 2.88% | 6 |
|
|
2022
Q1 | $14.6M | Hold |
1,565,526
| – | – | 3.67% | 7 |
|
|
2021
Q4 | $22.3M | Hold |
1,565,526
| – | – | 4.32% | 6 |
|
|
2021
Q3 | $36.3M | Sell |
1,565,526
-3
| -0% | -$70 | 5.7% | 5 |
|
|
2021
Q2 | $39M | Hold |
1,565,529
| – | – | 4.81% | 5 |
|
|
2021
Q1 | $43.9M | Buy |
1,565,529
+147,000
| +10% | +$4.12M | 8.09% | 3 |
|
|
2020
Q4 | $49.5K | Sell |
1,418,529
-73,634
| -5% | -$2.57K | 4.98% | 4 |
|
|
2020
Q3 | $74.4M | Sell |
1,492,163
-86,225
| -5% | -$4.3M | 20.74% | 1 |
|
|
2020
Q2 | $73.4M | Buy |
+1,578,388
| New | +$73.4M | 23.61% | 1 |
|